Showing results (11-20 of 227) with videos related to
Sort By:
Pageof 23
Journal of Neuroscience Methods|December 7, 2002
Modified herpes simplex virus delivery of enhanced GFP into the central nervous systemVladislav M Sandler, Samuel Wang, Kamilla Angelo, et al.Oncotarget|April 2, 2011
miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumorsErdogan Pekcan Erkan, Xandra O Breakefield, Okay SaydamHuman Gene Therapy|March 28, 2002
Critical issues in gene therapy for neurologic diseaseGary Hsich, Miguel Sena-Esteves, Xandra O BreakefieldHuman Molecular Genetics|March 25, 2011
Genetic therapy for the nervous systemWilliam J Bowers, Xandra O Breakefield, Miguel Sena-EstevesTrends in Molecular Medicine|April 8, 2014
Extracellular vesicles: emerging targets for cancer therapyPieter Vader, Xandra O Breakefield, Matthew J A WoodMethods in Molecular Biology (Clifton, N.J.)|October 30, 2013
Noninvasive in vivo monitoring of extracellular vesiclesCharles P Lai, Bakhos A Tannous, Xandra O BreakefieldPain|September 1, 1996
Exclusion of p75NGFR and other candidate genes in a family with hereditary sensory neuropathy type IIGudarz Davar, Christo Shalish, Anat Blumenfeld, et al.Current Gene Therapy|December 8, 2004
Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirusAngelika Oehmig, Cornel Fraefel, Xandra O Breakefield, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2004
HSV-1 virions engineered for specific binding to cell surface receptorsPaola Grandi, Samuel Wang, Deborah Schuback, et al.Nature Reviews Bioengineering|October 17, 2025
Extracellular vesicles for the delivery of gene therapyEmilio Di Ianni, Wataru Obuchi, Koen Breyne, et al.Pageof 23